Information on how education and care services provide proactive and reactive management for children and young people with anaphylaxis or allergies.
Health support for anaphylaxis and severe allergies
The Anaphylaxis and severe allergies in education and care procedure (PDF 942KB) describes how education and care services manage anaphylaxis and severe allergies.
The Department for Education supports the use of The Australasian Society of Clinical Immunology and Allergy (ASCIA) Action Plans to provide instructions for the individual management of anaphylaxis and allergies. These are completed by a treating health professional.
Health support agreement
A health support agreement - HSP120 (DOC 243KB) and safety and risk management plan - HSP121 (DOC 147KB) may be completed, however generally the ASCIA Action Plan is all that is required to support children and young people with anaphylaxis or severe allergies in education and care. These are completed by the parent and education or care service to document specific risk minimisation strategies, individualised management and treatment for the child in the context of the education or care service.
The guide to planning health support – HSP125 can assist in the development of the health support agreement by prompting through a series of questions and considerations.
The Health Support Agreement should clearly identify cultural, spiritual and language needs.
Where medication is prescribed for anaphylaxis or allergies and this is included on the ASCIA Action Plan a medication agreement is NOT required.
Refer to medication management for further information.
All education and care staff are required to provide first aid measures following any ASCIA Action Plan or Health Support Agreement and contacting emergency services if required.
The ASCIA first aid for anaphylaxis provides instructions to manage mild to moderate allergic reactions and severe allergic reactions (anaphylaxis). First aid instructions are clearly documented on the ASCIA Action Plans.
The ASCIA how to give EpiPen® provides instructions for administering an adrenaline autoinjector. Administration instructions are also clearly documented on the device.
In all circumstances where an adrenaline autoinjector is administered in an education or care service an ambulance (000) is called and the care of the person transferred to the ambulance officer.
General use adrenaline autoinjector (EpiPen®)
All preschools and schools must have one clearly labelled ‘general use’ adrenaline autoinjector that has not been prescribed to a child or young person.
• Preschools must have one general use 0.15mg adrenaline autoinjector (eg EpiPen®Jr)
• Schools must have one general use 0.3mg adrenaline autoinjector (eg EpiPen®)
The department have purchased a bulk order of EpiPen®s as a once off strategy. When used or expired, the preschool or school will fund a replacement EpiPen® or EpiPen®Jr. The department are currently looking into strategies to ensure this is kept as cheap as possible for sites.
An EpiPen® is designed to be used by anyone in an emergency, including people without any training. Instructions are displayed on each device. A general use EpiPen® may be used for any child or young person, staff or visitor attending the site.
An information sheet for parents (PDF 165 KB) has been developed to inform parents and guardians of the general use EpiPen®. Education and care services should ensure this information is communicated to the school community at least annually.
Training and education
Education and care services must have at least one designated first aider trained in HLTAID004 Emergency First Aid Response in an Education and Care Setting in attendance at all times who is immediately available to administer first aid and emergency response medication. This training includes anaphylaxis first aid.
Education and care staff are encouraged to complete the free ASCIA anaphylaxis e-training for Australasian early childhood or ASCIA anaphylaxis e-training for Australasian schools accessible via the ASCIA e-Training website and undertake practical training in the use of an adrenaline autoinjector.
The Royal District Nursing Service (RDNS) provide Anaphylaxis education. For training enquiries contact RNDS
• Phone: 1300 364 264
• Email: firstname.lastname@example.org
The Allergy and Anaphylaxis Australia Be a M.A.T.E program is an educational awareness program designed to help parents and education staff to teach students and staff about food allergies and how to help their friends who are at risk of anaphylaxis. The Be a M.A.T.E. resources help increase allergy awareness and understanding within the whole school community.
Health support agreement
- HSP120 Health support agreement
- HSP121 Safety and risk management plan
- HSP122 Offsite safety and risk management plan
First aid plan
- Incident and Response Management System (IRMS) (staff login required)
- HSP157 Medication advice form
- HSP323 Medical advice form for anaphylaxis and severe allergies
Planning and management tools
- Management of anaphylaxis flowchart
- Planning and documentation for anaphylaxis and severe allergies flowchart
- HSP321 Anaphylaxis risk assessment
- HSP322 Review of adrenaline autoinjectors
- HSP154 decision making tool for medication administration (DOC 157KB)
- Information sheet for parents – epipen and anaphylaxis
- HSP125 Guide to health support planning (DOC 87KB)
Disability and complex needs team
Phone: 8226 0515
Email: education.health [at] sa.gov.au